Organometallic Compounds
![eMolecules 552-38-5 | Lithium salicylate | Chem-Impex | MFCD00045813 | 144.050 | C7H5LiO3 | 99.000 | [Li+].Oc1ccccc1C([O-])=O | 25g | 205002558](https://assets.fishersci.com/TFS-Assets/CCG/product-images/501716509.jpg-250.jpg)
eMolecules 552-38-5 | Lithium salicylate | Chem-Impex | MFCD00045813 | 144.050 | C7H5LiO3 | 99.000 | [Li+].Oc1ccccc1C([O-])=O | 25g | 205002558
Lithium salicylate | Chem-Impex | 552-38-5 | MFCD00045813 | 144.050 | C7H5LiO3 | 99.000 | [Li+].Oc1ccccc1C([O-])=O | 25g | 205002558
Apexbio Technology LLC Epidermal growth factor receptor (994-1002) acetyl/amide 10mg
Epidermal growth factor receptor 994-1002 acetyl amide is a peptide fragment derived from the epidermal growth factor receptor (EGFR) acetylated and amidated at its termini It is designed to serve as a tool for investigating receptor-ligand interactions and receptor activation mechanisms associated with EGFR-mediated signaling pathways Epidermal growth factor receptor 994-1002 acetyl amide acts by enabling the study of EGFR activation particularly receptor dimerization and autophosphorylation processes Based on its biological characteristics this peptide has research potential in evaluating therapeutic strategies targeting EGFR-mediated oncogenesis including studies of proliferation differentiation migration and survival in malignancies such as glioblastoma and lung cancers
Apexbio Technology LLC Benzoquinonium dibromide 311-09-1 50mg
Benzoquinonium dibromide is a small-molecule antagonist targeting nicotinic acetylcholine receptors (nAChRs) It is designed to inhibit neuronal acetylcholine receptor channel activity thereby regulating cholinergic neurotransmission Benzoquinonium dibromide exerts its biological activity primarily through blockade of nAChRs affecting the permeability of Na and K ions across neuronal membranes In in vitro studies using cultured fetal rat hippocampal neurons Benzoquinonium dibromide demonstrates dual effects at concentrations of 0 1 10 M it activates ion channel currents at conductance states of approximately 43 pS and 30 pS while also exhibiting channel-blocking activity at the open-channel state Based on these pharmacological properties Benzoquinonium dibromide holds research potential in neuropharmacology and neurophysiology for investigating cholinergic signaling pathways receptor activation mechanisms and receptor-channel interactions
eMolecules 83622-41-7 | 2-(Dichloromethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ChemScene | MFCD27976342 | 210.890 | C7H13BCl2O2 | 97.000 | CC1(C)OB(OC1(C)C)C(Cl)Cl | 25g | 893915042
2-(Dichloromethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ChemScene | 83622-41-7 | MFCD27976342 | 210.890 | C7H13BCl2O2 | 97.000 | CC1(C)OB(OC1(C)C)C(Cl)Cl | 25g | 893915042
eMolecules 5222-73-1 | 3,4-Dimethoxy-3-cyclobutene-1,2-dione | Combi-Blocks | MFCD00101316 | 142.110 | C6H6O4 | 97.000 | COc1c(OC)c(=O)c1=O | 1g | 205406818
3,4-Dimethoxy-3-cyclobutene-1,2-dione | Combi-Blocks | 5222-73-1 | MFCD00101316 | 142.110 | C6H6O4 | 97.000 | COc1c(OC)c(=O)c1=O | 1g | 205406818
Medchemexpress LLC DOTA-EB-TATE | 2151063-66-8 | 95.4% | 2329.63 | 5 MG
This peptide drug conjugate (PDC) is composed of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB). It is designed to improve the pharmacokinetics of SSTR2 analogs and reduce PRRT toxicity, and can also be utilized for the synthesis and research of Radionuclide-Drug Conjugates (RDCs).
- Composed of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB)
- Improves pharmacokinetics of SSTR2 analogs
- Reduces PRRT toxicity
- Utilized for the synthesis and research of Radionuclide-Drug Conjugates (RDCs)
Medchemexpress LLC DOTA-EB-TATE | 2151063-66-8 | 95.4% | 2329.63 | 1 MG
DOTA-EB-TATE is a peptide drug conjugate (PDC) consisting of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB). It is designed to enhance the pharmacokinetics of SSTR2 analogs and reduce PRRT toxicity.
- Enhances pharmacokinetics of SSTR2 analogs
- Reduces PRRT toxicity
- Useful for synthesis and research of Radionuclide-Drug Conjugates (RDCs)
- Functions as a peptide drug conjugate (PDC)
- Applicable in cancer targeted therapy
- Used in cancer metabolism and metastasis research
Apexbio Technology LLC IDE 1 1160927-48-9 1mg
IDE 1 (CAS 1160927-48-9) is a small-molecule compound designed to promote differentiation of stem cells toward the definitive endoderm lineage by activating receptors involved in the TGF- signaling pathway IDE 1 exerts its biological activity primarily through activation of the TGF- signaling pathway In in vitro studies IDE 1 induces definitive endoderm specification from pluripotent stem cells Based on these pharmacological properties IDE 1 holds research potential in in vitro differentiation protocols to generate endoderm-derived cells such as hepatocytes and pancreatic cells and in studies investigating early embryonic lineage commitment and regenerative medicine
Apexbio Technology LLC OSI-930 728033-96-3 100mg
OSI-930 (CAS 728033-96-3) is a small molecule inhibitor targeting multiple receptor tyrosine kinases including Flt1 (IC 8 nM) KDR/VEGFR2 (IC 9 nM) CSF-1R (IC 15 nM) Lck c-Raf and Kit (IC 80 nM) In cellular studies OSI-930 inhibits proliferation and induces apoptosis in HMC-1 cells whose survival is dependent on Kit signaling while exhibiting minimal effects on COLO-205 cells under standard conditions Additionally OSI-930 inactivates cytochrome P450 3A4 in a time- and concentration-dependent manner and alters its spectral properties These characteristics make OSI-930 a valuable tool compound for investigating receptor tyrosine kinase signaling pathways and related cellular processes in cancer research
Apexbio Technology LLC Endothelin-1 (1-15), amide, human 1mg
Endothelin-1 1-15 amide human is a peptide fragment derived from the N-terminus of Endothelin-1 which targets endothelin receptor subtypes ETA and ETB It is designed to modulate vascular tone through activation of G protein-coupled receptor signaling thereby influencing blood pressure regulation and vascular function Endothelin-1 1-15 amide human exerts its biological activity primarily through receptor activation and signal transduction mechanisms involving endothelin receptors Based on these pharmacological properties Endothelin-1 1-15 amide human holds research potential in the investigation of receptor-ligand interactions receptor selectivity and the pathophysiology of hypertension cancer diabetes pain modulation and cerebral vasospasm
Medchemexpress LLC Triisopropylsilane | 6485-79-6 | MFCD00009657 | 500g
Triisopropylsilane 98% is a strong reducing agent